Interventions for managing medication-related osteonecrosis of the jaw-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Interventions for managing medication-related osteonecrosis of the jaw

Published:2017-10-06 Issue:10 Volume:2017 Page:
ISSN:1465-1858
Container-title:Cochrane Database of Systematic Reviews
language:en
Short-container-title:

Author:

Beth-Tasdogan Natalie H¹,Mayer Benjamin²,Hussein Heba³,Zolk Oliver¹

Affiliation:

1. Ulm University; Institute of Pharmacology of Natural Products & Clinical Pharmacology; Helmholtzstr. 20 Ulm Germany 89081

2. Ulm University; Institute of Epidemiology and Medical Biometry; Schwabstr. 13 Ulm Germany 89075

3. Faculty of Dentistry, Cairo University; Department of Oral Medicine, Diagnosis, and Periodontology; Cairo Egypt

Publisher

Wiley

Subject

Pharmacology (medical)

Reference95 articles.

1. What is the role of hyperbaric oxygen in the management of bisphosphonate-related osteonecrosis of the jaw: a randomized controlled trial of hyperbaric oxygen as an adjunct to surgery and antibiotics;Freiberger;Journal of Oral and Maxillofacial Surgery,2012

2. NCT00462098 Randomized controlled trial of hyperbaric oxygen in patients who have taken bisphosphonates clinicaltrials.gov/show/NCT00462098

3. Tooth extraction in patients on zoledronic acid therapy;Mozzati;Oral Oncology,2012

4. A dental extraction protocol with plasma rich in growth factors (PRGF) in patients on intravenous bisphosphonate therapy: a case-control study;Mozzati;Joint, Bone, Spine,2011

5. Tooth extraction in osteoporotic patients taking oral bisphosphonates;Mozzati;Osteoporosis International,2013

Cited by 158 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The adjunctive use of Leukocyte-Platelet Rich Fibrin (L-PRF) in the management of Medication Related Osteonecrosis of the Jaw (MRONJ): a retrospective observational study;Oral and Maxillofacial Surgery;2024-09-03

2. The Management of Medication-Related Osteonecrosis of the Jaw: An Overview of National and International Guidelines;British Journal of Oral and Maxillofacial Surgery;2024-09

3. A real-world disproportionality analysis of FDA adverse event reporting system (FAERS) events for denosumab;Frontiers in Pharmacology;2024-08-30

4. Bisphosphonate- and disumab-related gingival disorders: case analysis from the U.S. Food and Drug Administration Adverse Event Reporting System;Frontiers in Endocrinology;2024-08-22

5. How we manage medication-related osteonecrosis of the jaw;European Journal of Medical Research;2024-08-02

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3